Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
YP05002 and Pipeline Strategy YP05002 is a small-molecule GLP-1 agonist that Yao Pharma has indicated has therapeutic potential beyond weight loss, including in conditions such as diabetes and metabolic dysfunction-associated steatohepatitis (MASH)
Chad Larson evaluates each patient through comprehensive metabolic testing before recommending treatment
Practical experience to date has shown it is a good guide to real performance
it has been shown to be an efficient inhibitor of Jun kinase (also known as stress-activated kinase), the enzyme that activates c-jun and several other transcription factors (Adler et al ., 1999)
US$ 21.98
US$ 28.51
US$ 23.86
US$ 27.09
US$ 25.13
